Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration

Overview of attention for article published in Current opinion in ophthalmology, May 2009

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 9 patents

Readers on

mendeley: 62 Mendeley

So far, Altmetric has seen 9 patents that reference this research output.

Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative diabetic…

Grant US-12280093-B2

United States of America

22 Apr 2025

Use of a VEGF antagonist to treat angiogenic eye disorders

Grant US-12268730-B2

United States of America

08 Apr 2025

Use of a VEGF antagonist to treat angiogenic eye disorders

Grant US-11986511-B2

United States of America

21 May 2024

Use of a VEGF antagonist to treat angiogenic eye disorders

Grant US-11975045-B2

United States of America

07 May 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.